An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters - Test2 - elhamkhani - TriplyDB

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

http://www.wikidata.org/entity/Q35083450

about

Irinotecan changes gene expression in the small intestine of the rat with breast cancer Light-emitting diode therapy in chemotherapy-induced mucositis.RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients Drug delivery strategies for common orofacial diseases.Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues.Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?Evaluation of current and upcoming therapies in oral mucositis prevention.Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation.A Rapid Response to Matrix Therapy With RGTA in Severe Epidermolysis Bullosa Healing action of topical chamomile on 5-fluoracil induced oral mucositis in hamster.Periodontitis destructions are restored by synthetic glycosaminoglycan mimetic.Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro.Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic.Periodontal reconstruction by heparan sulfate mimetic-based matrix therapy in -infected mice

P2860

Q28577612-B0788342-9A3B-4B4E-96C1-A8A38DB8093B Q33379394-3261FB58-04CF-43DB-B79C-587F5A28E9BF Q33844218-0661D81C-C5F0-401F-9281-AAE360F4B288 Q36627793-07F278A4-5795-41B6-8FFF-026AAC48D7AA Q36994259-69E3F69D-8D64-40DF-8640-D19B82B8F3CF Q37071033-59CFC390-C790-4DCA-9FC1-45A7BC88D36C Q37420505-E86FCC66-E8B3-480F-81E3-219AE351A7AD Q37818225-75B389A9-AF2A-4784-93AA-69BBB0A5401B Q38019401-8EFD4E0F-9F19-40AA-8EA3-7969E846B434 Q38049159-DC1CB3BB-C8FC-4369-A5F9-7CCED8845667 Q38625302-E741BBD2-4F63-4693-9871-07ACD9A3AA09 Q41876479-2FD6D65C-27DA-4477-B724-662B17A56465 Q51773901-A6031340-545C-4EDA-92DF-B4CBB892D8F5 Q51805981-E2A8B2BA-FEFE-4027-B616-D8D470DC1835 Q51807172-C1670A16-BF82-4C12-809C-3C4BAA492E6B Q51811662-85F46260-746E-412D-8614-4E00BFEE21B5 Q58799277-9095A2DD-2FB5-411C-BDE8-69E3148D5F47

P2860

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

http://www.wikidata.org/entity/Q35083450

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@ast

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@en

type

label

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@ast

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@en

prefLabel

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@ast

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@en

P1433

Q35083450-15C2DF2D-AF9F-44A8-9346-3D59AA66394A

P1476

Q35083450-7A72B400-C390-41C4-953C-6C8A890A17B1

P2093

Q35083450-232808D7-CDDA-4BEA-A0FC-91F4FC3AFE38

Q35083450-25641E2E-CFA9-4DC9-9F11-A4A02A546D0B

Q35083450-59F79BA1-CEA5-45DC-8F3D-F94BA8EDA42E

Q35083450-6A2953F1-AC98-4110-80FC-9A8C11EADA8C

Q35083450-6FDD89D9-9C6B-4B29-9763-ADCC1021B190

Q35083450-99FADA54-E9D7-4040-A50C-CA0ED5C9DCA8

P2860

Q35083450-13BAFB2C-9DBE-4C89-867F-5CEB72087ED7

Q35083450-1B7C7C16-F0AA-4BC6-AEAA-D866A2E80125

Q35083450-2570C5B0-D331-4D6F-BAB3-09E239028FA7

Q35083450-3408A83A-674F-45BC-BE30-9AA0E2DFAEB2

Q35083450-35BB7444-490D-4F8C-97AC-5E50FD0ED1C4

Q35083450-52E9E241-7503-4727-9174-473CEEEBC4B3

Q35083450-A170FABB-FCBD-473E-9AB3-35A17C3CF55B

Q35083450-A242390A-9FE7-41CB-ABAF-DFEDE9AFE5CB

Q35083450-AFC3E5E0-BCD6-4714-85A3-373BAF923D55

Q35083450-BD93D3FE-5D34-41A8-AE1A-ECE4DB8804EE

P304

Q35083450-CB7457C0-F21B-46A4-BF15-6682D78F5123

P31

Q35083450-6489BA13-C041-4AD4-8A23-C27041651C99

P356

Q35083450-6B4D5C0B-20E6-4BD2-B7F7-1A561319F036

P407

Q35083450-AF78304D-ED4F-4F3A-AF6E-E4FB6C5B1D33

P433

Q35083450-44582ACA-60DD-4F63-9856-6DE71C982FE2

P478

Q35083450-AF9FA299-8C88-464B-8D42-C4CF462BED84

P50

Q35083450-4F0D0523-C953-41B4-AFD2-81066ED7C0D8

P577

Q35083450-A9D3323E-8D57-4461-ADEB-37803270CCDA

P5875

Q35083450-63BC03B7-41CF-4196-8C0B-EF90142BC3DA

P698

Q35083450-B7A6C6FB-8DFF-4942-9FDD-7FBB4BD88112

P932

Q35083450-6B0E23CD-0506-4ABD-9E66-D8A532F74D20

P356

S0002-9440(10)63161-6

P1433

The American Journal of Pathology

P1476

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters

@en

P2093

Brigitte Baroukh

http://www.w3.org/2001/XMLSchema#string

Denis Barritault

http://www.w3.org/2001/XMLSchema#string

Dominique Ledoux

http://www.w3.org/2001/XMLSchema#string

Frédéric O Morvan

http://www.w3.org/2001/XMLSchema#string

Gaston Godeau

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Caruelle

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review.

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

Still more complexity in mammalian basement membranes.

Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Matrix remodelling enzymes, the protease cascade and glycosylation.

The binding of heparin to type IV collagen: domain specificity with identification of peptide sequences from the alpha 1(IV) and alpha 2(IV) which preferentially bind heparin.

Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF.

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis.

Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster.

Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.

P304

739-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63161-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

Jean-louis Saffar

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7957717

http://www.w3.org/2001/XMLSchema#string

P698

14742277

http://www.w3.org/2001/XMLSchema#string

P932

1602269

http://www.w3.org/2001/XMLSchema#string